CRIS Current Research Information System

GIOVANNINI, CATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.011
NA - Nord America 3.245
EU - Europa 2.911
AF - Africa 258
SA - Sud America 219
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.188
CN - Cina 1.127
SG - Singapore 1.032
IT - Italia 917
VN - Vietnam 897
GB - Regno Unito 449
HK - Hong Kong 266
DE - Germania 255
SE - Svezia 243
FR - Francia 185
IN - India 175
NL - Olanda 169
KR - Corea 157
BR - Brasile 153
CH - Svizzera 125
RU - Federazione Russa 98
FI - Finlandia 91
UA - Ucraina 88
IE - Irlanda 86
JP - Giappone 80
ZA - Sudafrica 65
CI - Costa d'Avorio 59
TG - Togo 49
CA - Canada 39
BG - Bulgaria 38
ID - Indonesia 34
SC - Seychelles 33
PH - Filippine 32
JO - Giordania 31
EE - Estonia 30
TH - Thailandia 29
EC - Ecuador 25
PL - Polonia 23
BE - Belgio 21
PK - Pakistan 21
BD - Bangladesh 19
ES - Italia 18
TR - Turchia 18
AR - Argentina 17
AT - Austria 15
MX - Messico 14
NG - Nigeria 14
TW - Taiwan 13
DZ - Algeria 12
SA - Arabia Saudita 11
CZ - Repubblica Ceca 9
IL - Israele 9
IQ - Iraq 9
MK - Macedonia 9
UZ - Uzbekistan 9
HR - Croazia 8
GR - Grecia 7
MY - Malesia 7
RO - Romania 7
TN - Tunisia 7
CO - Colombia 6
LT - Lituania 6
NP - Nepal 6
AU - Australia 5
LB - Libano 5
AM - Armenia 4
ET - Etiopia 4
PE - Perù 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
GH - Ghana 2
KZ - Kazakistan 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
Totale 10.649
Salva come PNG Salva come JPEG
Città #
Singapore 713
Ashburn 438
Southend 355
Hefei 321
Bologna 302
Fairfield 247
Hong Kong 243
Chandler 225
Ho Chi Minh City 216
Hanoi 187
San Jose 181
Seoul 142
Santa Clara 132
Bern 119
Wilmington 119
Houston 118
Woodbridge 118
Beijing 108
Boardman 97
Seattle 89
Dublin 86
Princeton 81
Ann Arbor 77
Dallas 76
Council Bluffs 74
Helsinki 73
Milan 73
Cambridge 72
Lauterbourg 70
Los Angeles 68
Tokyo 64
Abidjan 59
Jacksonville 52
Lomé 49
New York 45
Da Nang 38
Sofia 38
Dong Ket 37
Florence 37
Nanjing 35
Padova 34
Turin 34
Westminster 33
Haiphong 32
Amman 31
Bengaluru 30
Johannesburg 30
Amsterdam 29
Buffalo 26
Redondo Beach 26
Berlin 25
Chicago 25
Munich 25
Jinan 24
Jakarta 22
Frankfurt am Main 20
London 19
San Diego 19
Changsha 17
Saint Petersburg 17
São Paulo 17
Guangzhou 16
Hebei 16
Rome 16
Shanghai 16
Warsaw 15
Brussels 14
Düsseldorf 14
Pune 14
Jiaxing 13
Montreal 13
Shenyang 13
The Dalles 13
Verona 13
Zhengzhou 13
Can Tho 12
Curitiba 12
Genoa 12
Lahore 12
Orem 12
Abeokuta 11
Bangkok 11
Brooklyn 11
Chennai 11
Medford 11
Mülheim 11
Nuremberg 11
Tongling 11
Edmonton 10
Guayaquil 10
Haikou 10
Hangzhou 10
Hải Dương 10
Norwalk 10
Paris 10
Phoenix 10
Tianjin 10
Wuhan 10
Lappeenranta 9
Nanchang 9
Totale 6.674
Salva come PNG Salva come JPEG
Nome #
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 257
Metodo per valutare la capacità di un siero di neutralizzare un virus 247
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 230
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 229
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 226
Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies 226
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 223
LncRNAs as novel players in hepatocellular carcinoma recurrence 221
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 211
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 211
Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation 206
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 203
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 200
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland 198
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 191
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 185
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 184
Determinazione della telomerasi nei tumori mammari della cagna: due metodi a confronto 181
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 180
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 179
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 176
Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction. 176
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) 176
Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. 174
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 174
Organic Electrochemical Transistor (OECT) for Real Time, Electrical quantification of SARS CoV 2 neutralizing antibodies 173
CARCINOMA COMPLETAMENTE NEUROENDOCRINO DELLA VESCICA IN GIOVANE PAZIENTE DI 37 ANNI: CASO CLINICO 172
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 172
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 170
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease 167
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 166
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 161
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 161
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research 158
Pharmaceutical composition and pharmaceutical kit for the treatment oh hepatocellular carcinoma 155
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 155
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 153
Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation. 153
Organic Electrochemical Transistors as Versatile Tool for Real-Time and Automatized Viral Cytopathic Effect Evaluation 151
MicroRNAs in Animal Models of HCC 149
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies 147
PEDOT:PSS OECTs as versatile devices for real-time monitoring of cytotoxicity and viral infection 147
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions 144
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 138
OECTs for in-vitro, real-time impedance monitoring: from single cell sensing to tissue integrity 136
Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Anticancer Res. 2006 May-Jun;26(3A):1849-54. 135
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. 135
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC 134
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. 134
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 133
Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. 133
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA 129
p66Shc/Notch-3 interplay controls self renewal and hypoxia survival inhuman stem/progenitor cells of the mammary gland expanded in vitro as mammo-spheres. 126
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells 119
Notch3 intracellular domain accumulates in HepG2 cell line. 109
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma 109
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 108
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas 107
Expression of Fli-1 leads to increased notch activity through overexpression of fringe in colorectal cancer (CRC). 102
Checkpoint effectors CDKN1A and Gadd45 correlate with oxidative DNA damage in human prostate carcinoma. 101
Corrigendum: Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation (Frontiers in Physiology, (2023), 14, (1129278), 10.3389/fphys.2023.1129278) 89
PEDOT:PSS OECTs as versatile devices for real-time monitoring cytotoxicity and viral infection 83
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 77
PEDOT:PSS OECTs as versatile devices for monitoring cytotoxicity and viral infection in real-time 72
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 70
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 59
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 54
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 53
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 51
Scaling up in-vitro, real-time cell monitoring through large area printing of PEDOT:PSS OECTs 51
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 51
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 45
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 36
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 36
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 34
Totale 10.867
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 50 32 140
2021/2022910 73 35 63 84 69 44 16 79 37 81 211 118
2022/20231.201 111 135 83 132 68 100 22 65 185 29 94 177
2023/2024508 38 61 22 48 31 96 31 46 30 44 26 35
2024/20251.832 86 220 168 105 191 72 140 69 71 181 150 379
2025/20264.559 447 500 425 380 425 274 556 223 1.044 285 0 0
Totale 10.867